Remco Lemarcq’s first in-house role was acting as lead counsel for sixteen countries in Central and Eastern Europe. Now, as global head counsel of plasma-derived therapies at Takeda, Lemarcq supports end-to-end operations of the company’s plasma business, including a network of over two hundred plasma donation centers, manufacturing, research and development, and more.
Global Head Counsel, Plasma-Derived Therapies
Growing up in Belgium, a country where education and healthcare are virtually free, Lemarcq says he is ever aware of his privilege and has worked to grow his truly global worldview. It’s made him passionate about diversity, equity, and inclusion, and the attorney is currently leading diversity, equity, and inclusion efforts for global legal at Takeda. These efforts include a pro bono program that helps lawyers make a direct impact on communities by supporting those who need it most.
The lawyer’s defining moment thus far includes the creation of an eight-company collaboration agreement to combat the COVID-19 pandemic in 2020.
“Instead of pursuing individual projects, we have set aside company interests to work together on the development of a non-branded plasma-derived therapy, called a hyperimmune globulin,” the lawyer explains. “The need to be agile and pragmatic has provided great learnings to the entire team, and we continue to benefit from this.”